Thursday, November 9, 2017

Dynavax (DVAX) Reports FDA Approval of HEPLISAV-B for Prevention of Hepatitis B in Adults

  1. Dynavax (DVAX) Reports FDA Approval of HEPLISAV-B for Prevention of Hepatitis B in Adults  StreetInsider.com
  2. HEPLISAV-B Approved by FDA  Contagionlive.com
  3. Dynavax Hep B vaccine gets FDA approval  Daily MailFull coverage
(CLICK HERE TO READ AND SEE MORE

0 comments:

Post a Comment